Chu Linyang, Jiang Guoqiang, Hu Xi-Le, James Tony D, He Xiao-Peng, Li Yaping, Tang Tingting
Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P. R. China.
J Mater Chem B. 2018 Jul 7;6(25):4197-4204. doi: 10.1039/c8tb00766g. Epub 2018 May 31.
Bone grafting remains the method of choice for the majority of surgeons in the treatment of large bone defects, since it fills spaces and provides support to enhance biological bone repair. Recently, we have reported our research on a bioactive multiphase macroporous scaffold with interconnected porous structures and nano-crystal surface microstructures that can release bioactive ions. Moreover, we demonstrated the excellent in vitro biological activity of the scaffold. In this study, we set out to evaluate the in vivo osteogenesis and vascularization of the scaffold in the treatment of large bone defects (10 mm radial bone defect in rabbits). In comparison with the control group, X-ray and micro-CT results at the 4th and 8th week post-surgery reveal that the bioactive scaffold displayed an enhanced level of new bone and vessel formation. Histological results at the same weeks indicated improved bone formation, osseointegration and new vessel ingrowth inside the bioactive scaffold. These findings establish a good foundation for the potential clinical validation of the bioactive macroporous biomaterial scaffold for use as a bone substitute or in tissue engineering.
骨移植仍然是大多数外科医生治疗大骨缺损的首选方法,因为它能填充骨缺损部位并提供支撑,以促进生物性骨修复。最近,我们报道了关于一种具有相互连通的多孔结构和能释放生物活性离子的纳米晶体表面微观结构的生物活性多相大孔支架的研究。此外,我们还证明了该支架具有出色的体外生物活性。在本研究中,我们着手评估该支架在治疗大骨缺损(兔桡骨10毫米骨缺损)中的体内成骨和血管化情况。与对照组相比,术后第4周和第8周的X射线和显微CT结果显示,生物活性支架的新骨形成和血管生成水平有所提高。同一时期的组织学结果表明,生物活性支架内部的骨形成、骨整合和新血管长入情况有所改善。这些发现为生物活性大孔生物材料支架作为骨替代物或用于组织工程的潜在临床验证奠定了良好基础。